The Next platform will analyze clinical data from mBC patients treated in certain centers and notify clinicians when ESR1 testing is missing at disease progression.
Tempus AI,...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a new collaboration with the...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, introduced a suite of new, transformative...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announces an expansion to its collaboration...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced the launch of a new program specifically geared towards using algorithms to...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced an expanded collaboration with Remix Therapeutics, a clinical-stage biotechnology company developing small...